STATUS OF TREATMENT OF VASCULAR DEMENTIA

The therapeutic goal in treating vascular dementia has been based on i ts presumed association with cerebral arteriosclerosis. Therefore, it is necessary to control risk factors for arteriosclerosis. In this con nection, application of platelet-aggregating substances has been used extensively, Promising results have also been observed by altering the hemorheologic profile because hemorheologically active substances may be able to ameliorate the course of vascular dementia. Further improv ement could be achieved by application of the HELP system to enhance t he effect of hemorheologically active drugs, Using the HELP system, LD L, cholesterol, triglycerides and fibrinogen can be lowered considerab ly and may result in clinical improvement or slowing of the progressio n of vascular dementia.